Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fielmann Group AGXSWX:FIE 86 EV-to-EBIT is 12.55 as of Jul. 19, 2026, which is 39% below its 10-year median of 20.43. GuruFocus rates XSWX:FIE with a GF Score™ of 86/100 and a GF Value™ of CHF49.97. The stock has 2 warning signs investors should review. Among 465 Medical Devices & Instruments companies, Fielmann Group AG ranks better than 69.03% on this metric.
The historical rank and industry rank for Fielmann Group AG's EV-to-EBIT or its related term are showing as below:
XSWX:FIE'
s EV-to-EBIT Range Over the Past 10 Years
Min: 10.61 Med: 20.43 Max: 35.43
Current: 12.64
During the past 13 years, the highest EV-to-EBIT of Fielmann Group AG was 35.43. The lowest was 10.61. And the median was 20.43.
XSWX:FIE's EV-to-EBIT is ranked better than 69.03% of 465
companies
in the Medical Devices & Instruments industry
Industry Median: 18.43
vs XSWX:FIE: 12.64
Fielmann Group AG (XSWX:FIE) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Fielmann Group AG's Enterprise Value for the quarter that ended in Mar. 2026 was CHF3,300 Mil.
Fielmann Group AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF294 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fielmann Group AG EV-to-EBIT Related Terms
Fielmann Group AG EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Fielmann Group AG's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:FIE vs ISRG, BDX, MDLN: EV-to-EBIT Comparison
For the Medical Instruments & Supplies subindustry, Fielmann Group AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fielmann Group AG EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fielmann Group AG's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Fielmann Group AG's EV-to-EBIT falls into.
Fielmann Group AG's current Enterprise Value is CHF3,685 Mil.
Fielmann Group AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF294 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fielmann Group AG (XSWX:FIE) has a EV-to-EBIT of 12.55 as of Jul. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Fielmann Group AG and its competitors. This is 39% below median its historical median of 20.43. Over the past decade, Fielmann Group AG's EV-to-EBIT has ranged from 10.61 to 35.43. According to the industry distribution chart, Fielmann Group AG ranks #144 out of 465 companies in the Medical Devices & Instruments industry, placing it in the top 31%.
Is Fielmann Group AG's EV-to-EBIT too high?
Fielmann Group AG's current EV-to-EBIT of 12.55 is 39% below median its 10-year median of 20.43. Over the past 10 years, this metric has ranged from a low of 10.61 to a high of 35.43. The Medical Devices & Instruments industry median EV-to-EBIT is 18.43. Fielmann Group AG's value of 12.55 is 31.9% below this industry median. Based on the distribution chart, Fielmann Group AG ranks #144 out of 465 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fielmann Group AG has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fielmann Group AG ranks #144 out of 465 companies for EV-to-EBIT. This puts Fielmann Group AG in the upper half of its industry. The industry median EV-to-EBIT is 18.43. Fielmann Group AG's value of 12.55 is 31.9% below this benchmark. Historically, Fielmann Group AG's own EV-to-EBIT has ranged from 10.61 to 35.43 over the past decade. While the company's 10-year median is 20.43 vs. the industry median of 18.43, Fielmann Group AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.43, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fielmann Group AG's current EV-to-EBIT of 12.55 is 31.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Fielmann Group AG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current EV-to-EBIT is 12.55, which is 39% below median its own 10-year median of 20.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Fielmann Group AG (XSWX:FIE) has a current EV-to-EBIT of 12.55. The stock's GF Value™ is CHF49.97, compared to a current price of CHF37.15 — trading 25.7% below its estimated fair value. The current EV-to-EBIT is 12.55, which is 39% below median its 10-year median of 20.43 and 31.9% below the Medical Devices & Instruments industry median of 18.43. Fielmann Group AG's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Fielmann Group AG (XSWX:FIE), the current EV-to-EBIT is 12.55 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fielmann Group AG (XSWX:FIE) Overvalued in 2026?
Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued.
The current stock price of CHF37.15 is trading 25.7% below its estimated GF Value™ of CHF49.97.
Key valuation signals for XSWX:FIE:
EV-to-EBIT: 12.55 (39% below median its 10-year median of 20.43)
GF Value™: CHF49.97 vs. price of CHF37.15 (25.7% below fair value)
Industry Position: 31.9% below the Medical Devices & Instruments median (#144 of 465)
No single metric tells the full story. See the XSWX:FIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
86GF Score
Get the complete analysis for XSWX:FIE
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FIE has been successfully added to your 
